Impact of Formulary Coverage of Entresto (Sacubitril/Valsartan) on Prescription Abandonment/Rejection and Subsequent Treatment and Economic Outcomes in Chronic Heart Failure Patients in the U.S.
Clinical trial NCT05848206 · COMPLETED
Trial details
- NCT number
- NCT05848206
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-03-11
- Primary completion
- 2022-04-29
- Enrollment
- 251831
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.